VAD with or without subsequent high-dose melphalan followed by autologous stem cell support in AL amyloidosis: Japanese experience and criteria for patient selection

By Gono Takahisa   Matsuda Masayuki   Shimojima Yasuhiro   Ishii Wataru   Koyama Jun   Sakashita Kazuo   Koike Kenichi   Hoshii Yoshinobu   Ikeda Shu-ichi  

Amyloid: The Journal of Protein Folding Disorders, Vol. 11, Iss. 4, 2004-12 ,pp. : 245-256

Informa Healthcare

Access to resources Recommend Favorite

Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: A case report with literature review

By Tam Martin   Seldin David   Forbes Benjamin   Connors Lawreen   Skinner Martha   Oran Betul   Quillen Karen   Sanchorawala Vaishali  

Amyloid: The Journal of Protein Folding Disorders, Vol. 16, Iss. 2, 2009-06 ,pp. : 103-107

Informa Healthcare

Access to resources Recommend Favorite

Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea

By Kim Seok Jin   Lee Ga Yeon   Jang Hye Ryoun   Choi Jin-Oh   Kim Jung Sun   Kim Hee-Jin   Lee Soo-Youn   Min Ju-Hong   Jeon Eun-Seok   Kim Kihyun  

Amyloid: The Journal of Protein Folding Disorders, Vol. 20, Iss. 4, 2013-12 ,pp. : 204-211

Informa Healthcare

Access to resources Recommend Favorite

Autologous hematopoietic stem cell transplantation: a cure for multiple sclerosis?

By Libbey Jane E   Tsunoda Ikuo   Fujinami Robert S  

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 403-408

Future Medicine

Access to resources Recommend Favorite

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis

By Metz Imke  

Brain, Vol. 130, Iss. 5, 2007-05 ,pp. : 1254-1262

Oxford University Press

Access to resources Recommend Favorite